About
Johnson & Johnson is an American multinational pharmaceutical and medical technologies corporation founded in 1886. It uses quantum computing for molecular simulations, optimization problems in drug discovery, and computational chemistry. In 2021, its Janssen Pharmaceuticals subsidiary launched a three-year research collaboration with Qu&Co to develop and test quantum computational algorithms and software for pharmaceutical R&D. Janssen used Qu&Co's QUBEC platform for quantum computational chemistry and materials science, testing algorithms on quantum processors. In 2024, Johnson & Johnson partnered with Pasqal to demonstrate practical benefits of quantum computing for drug discovery problems. The company is among the biggest pharmaceutical industry players submitting quantum computing patents, alongside Merck, Roche, and Amgen. Johnson & Johnson serves the global pharmaceutical market, applying quantum-enhanced drug discovery, molecular modeling, and computational chemistry to develop treatments for cancer, Alzheimer's, Parkinson's, and other conditions, with the goal of accelerating the path from discovery to clinical trials.
Quantum Specifications
| Quantum Focus | software |
Backed By
Application Areas
Frequently Asked Questions
Related News
Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report?
Johnson & Johnson: Why I See Downside Ahead
Morgan Stanley has a bold message for Johnson & Johnson
Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today
